Clinical trial
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving…
NCT00250029 · New Mexico Cancer Research Alliance, Other · Completed
Key facts
| NCT number | NCT00250029 |
|---|---|
| Title | Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen |
| Official title | Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy |
| Lead sponsor | New Mexico Cancer Research Alliance, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colonic Diseases, Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin |
| Enrollment | 30 |
| Start date | Apr 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Nov 7, 2005 |
| Last update posted | Sep 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: